[{"address1": "7921 Southpark Plaza", "address2": "Suite 210", "city": "Littleton", "state": "CO", "zip": "80120", "country": "United States", "phone": "844 672 4357", "website": "https://www.vivos.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.", "fullTimeEmployees": 109, "companyOfficers": [{"maxAge": 1, "name": "Mr. R. Kirk Huntsman", "age": 66, "title": "Co-Founder, Chairman of the Board & CEO", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 505328, "exercisedValue": 0, "unexercisedValue": 7640}, {"maxAge": 1, "name": "Mr. Bradford K. Amman", "age": 62, "title": "CFO, Treasurer & Secretary", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 315954, "exercisedValue": 0, "unexercisedValue": 5730}, {"maxAge": 1, "name": "Mr. Todd  Huntsman", "title": "Co-Founder & Senior VP of Product and Technology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. RaeAnn  Byrnes", "title": "Co-Founder and Senior VP of Events & Clinical Advisory Services", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Susan  McCullough", "title": "Co-Founder & Executive VP of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nicholas M. DeGennaro", "title": "Senior Vice President of Mergers and Acquisition Group", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ruth  Hembree", "title": "Senior Vice President of Practice Services", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Ballard", "title": "Senior Vice President of Technology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.71, "open": 2.64, "dayLow": 2.5535, "dayHigh": 2.66, "regularMarketPreviousClose": 2.71, "regularMarketOpen": 2.64, "regularMarketDayLow": 2.5535, "regularMarketDayHigh": 2.66, "payoutRatio": 0.0, "beta": 7.283, "forwardPE": -4.7818184, "volume": 54134, "regularMarketVolume": 54134, "averageVolume": 126041, "averageVolume10days": 90370, "averageDailyVolume10Day": 90370, "bid": 2.54, "ask": 2.66, "bidSize": 1, "askSize": 1, "marketCap": 15960603, "fiftyTwoWeekLow": 1.91, "fiftyTwoWeekHigh": 6.28, "priceToSalesTrailing12Months": 1.0618457, "fiftyDayAverage": 3.0565, "twoHundredDayAverage": 3.22761, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 10741438, "profitMargins": -0.74087, "floatShares": 5563888, "sharesOutstanding": 5889520, "sharesShort": 287716, "sharesShortPriorMonth": 344021, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.048899997, "heldPercentInsiders": 0.080010004, "heldPercentInstitutions": 0.12182, "shortRatio": 3.72, "shortPercentOfFloat": 0.0543, "impliedSharesOutstanding": 6068670, "bookValue": 1.351, "priceToBook": 1.9467063, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -11136000, "trailingEps": -2.22, "forwardEps": -0.55, "lastSplitFactor": "1:25", "lastSplitDate": 1698364800, "enterpriseToRevenue": 0.715, "enterpriseToEbitda": -1.014, "52WeekChange": 0.01544404, "SandP52WeekChange": 0.07995045, "quoteType": "EQUITY", "currentPrice": 2.63, "targetHighPrice": 6.2, "targetLowPrice": 5.5, "targetMeanPrice": 5.85, "targetMedianPrice": 5.85, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 6260000, "totalCashPerShare": 1.063, "ebitda": -10590000, "totalDebt": 1512000, "quickRatio": 1.344, "currentRatio": 1.501, "totalRevenue": 15031000, "debtToEquity": 19.009, "revenuePerShare": 2.994, "returnOnAssets": -0.53678, "returnOnEquity": -2.6625202, "grossProfits": 9019000, "freeCashflow": -8835875, "operatingCashflow": -12691000, "revenueGrowth": 0.139, "grossMargins": 0.60003, "ebitdaMargins": -0.70454, "operatingMargins": -0.75878996, "financialCurrency": "USD", "symbol": "VVOS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Vivos Therapeutics, Inc.", "longName": "Vivos Therapeutics, Inc.", "exchange": "NCM", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -2.9520266, "regularMarketPrice": 2.63, "corporateActions": [], "postMarketTime": 1745612032, "regularMarketTime": 1745611200, "messageBoardId": "finmb_529678289", "fiftyTwoWeekLowChange": 0.72000015, "fiftyTwoWeekLowChangePercent": 0.37696344, "fiftyTwoWeekRange": "1.91 - 6.28", "fiftyTwoWeekHighChange": -3.65, "fiftyTwoWeekHighChangePercent": -0.5812102, "fiftyTwoWeekChangePercent": 1.544404, "earningsTimestamp": 1743452400, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "earningsCallTimestampStart": 1743454800, "earningsCallTimestampEnd": 1743454800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.22, "epsForward": -0.55, "epsCurrentYear": -1.27, "priceEpsCurrentYear": -2.0708663, "fiftyDayAverageChange": -0.42649984, "fiftyDayAverageChangePercent": -0.13953865, "twoHundredDayAverageChange": -0.59761, "twoHundredDayAverageChangePercent": -0.18515557, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-12-11", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1607697000000, "postMarketChangePercent": 3.04182, "postMarketPrice": 2.71, "postMarketChange": 0.0799999, "regularMarketChange": -0.07999992, "regularMarketDayRange": "2.5535 - 2.66", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 126041, "displayName": "Vivos Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]